# Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

> **NCT02208102** · — · COMPLETED · sponsor: **Texas Cardiac Arrhythmia Research Foundation** · enrollment: 155 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Radio-frequency catheter ablation

## Key facts

- **NCT ID:** NCT02208102
- **Lead sponsor:** Texas Cardiac Arrhythmia Research Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-04
- **Final completion:** 2016-05
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02208102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02208102, "Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02208102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*